Or is it just healthcare reform risk being correctly priced by the market? Certainly on current fundies they look pretty cheap - solid dividends, low P/Es, and the analysts aren't expecting collapsing earnings anytime soon. They haven't really participated in the rally, some of them are still at Oct 2008 prices. Growth prospects are not amazing but these seem like solid blue chips at a fair price. Any thoughts?